Pliant Therapeutics, Inc. Share Price

Pliant Therapeutics, Inc. Share Price

NASDAQ: PLRX | Micro Cap
$0.86
-$0.01 (-0.82%) Last updated on 30 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Pliant Therapeutics, Inc. Stock Performance

Open
$0.87
Prev. Close
$0.87
Circuit Range
N/A
Day Range
$0.85 - $0.87
Year Range
$0.84 - $1.81
Volume
720
Average Traded
$0.86

Pliant Therapeutics, Inc. Share Price Today

As of 30 October 2026, Pliant Therapeutics, Inc.'s share price is $0.86. The stock opened at $0.87, compared to its previous close of $0.87. During today's trading session, Pliant Therapeutics, Inc.'s share price traded between $0.85 and $0.87, with an average price of $0.86. Over the past 52 weeks, the stock has recorded a high of $1.81 and a low of $0.84. In terms of performance, Pliant Therapeutics, Inc.'s share price has declined by 29.56% over the last six months and is down 48.79% on a year-on-year basis.

Pliant Therapeutics, Inc. Share Price Chart

Line chart of the Pliant Therapeutics, Inc. price trend over the selected period. The price fell overall, ranging from 0.85 to 0.88, ending at 0.86.
$0.85$0.87
L
Show Current Price
H

Pliant Therapeutics, Inc. Stock Fundamentals & Key Indicators

Market Cap
$52.95M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-1.49
Revenue (TTM)
$0.00
Return On Equity (TTM)
-62.81%
Profit Margin
N/A
Debt to Equity
0.00
Quarterly Earnings Growth YoY
14.94%

Pliant Therapeutics, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$26.30-$23.58-$20.04-$22.37
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A10.34%15.01%-11.63%

Pliant Therapeutics, Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$9.69$1.58$0.00$0.00
Net Profit-$123.32-$161.34-$210.30-$149.34
Net Profit Margin-1272.65%-10211.39%N/AN/A
Income ChangeN/A-30.83%-30.35%28.99%

About Pliant Therapeutics, Inc.

Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of integrin-based therapies. The company operates as a single reportable segment focused on developing and commercializing novel integrin-based treatments. Its lead product candidate, PLN-101095, is an oral small molecule targeting integrins for the treatment of solid tumors. The company also advances a pipeline of integrin-based programs across multiple disease areas through its proprietary drug discovery platform.

Pliant Therapeutics, Inc. Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Oct 2026
$1.09
$0.85
-21.11%
Sep 2026
$1.10
$1.08
-6.49%
Aug 2026
$1.05
$1.16
+10.53%
Jul 2026
$1.15
$1.04
-8.33%
Jun 2026
$1.25
$1.14
-10.24%
May 2026
$1.22
$1.27
+3.67%
Apr 2026
$1.29
$1.23
-3.92%
Mar 2026
$1.26
$1.27
-1.16%
Feb 2026
$1.22
$1.29
+5.74%
Jan 2026
$1.23
$1.22
+0.83%
Dec 2025
$1.58
$1.21
-24.84%
Nov 2025
$1.72
$1.61
-4.45%

PLRX Share Price FAQs